Submit your registration below.
This hands-on workshop will guide you through the commercialisation process step-by-step so you walk away with a clear commercial strategy.
Learn proven frameworks, tailored advice, and new ideas on how to articulate your business, engage with customers, and validate the market opportunity.
Who is it for?
Individuals and teams with an idea and want to develop a commercial plan.
Anyone wanting to understand how to assess which ideas have commercial potential and what to do next.
What's involved?
Consultant Paediatrician, Department of General Medicine at The Royal Children's Hospital
A/Professor Daryl Cheng lives and practices at the intersection of health, illness, technology and wellbeing. Bringing together his passion for holistic health, informatics, systems thinking and social enterprise, he works across a variety of environments and initiatives to improve life for children and their families.
Senior Director, R&D Strategy & Planning at Biointelect
At Biointelect, Patricia leads the R&D Strategy & Planning team, supporting a wide range of clients from universities, research institutions, government, start-up companies, biotech, medtech and pharma companies. She has led numerous projects at Biointelect in commercialisation strategy, business case development, planning and execution for key clients. She is particularly passionate about helping clients streamline their path to market using strategic project management techniques and thus commercialising their novel discoveries.
Principal of Griffith Hack
Dr Toby Thompson is a patent attorney and Principal of Griffith Hack, based in Melbourne. He specialises in life sciences and chemical inventions, in the areas of pharmaceuticals (e.g. small molecules, protein therapeutics, ADCs), animal healthcare, agrochemicals and chemical processes. Toby advises clients on global IP strategy, patent portfolio management, and patent drafting and prosecution.
Priority Manager of Australia's Economic Accelerator
Joe is the Priority Manager for Medical Science in the Australia’s Economic Accelerator (AEA) Program. Joe has a background in the pharmaceutical industry with 25 years of experience working in a variety of roles in multinational companies, SMEs and Government organisations in Australia, the UK and Asia, including 7 years in research collaboration and commercialisation at CSIRO.
CEO & Co-Founder of Celleo
David Kneen is CEO and co-Founder of Celleo, an Australian company delivering Intelligent Production Systems for Cell Therapy. Celleo’s customers include the world’s leading biopharma’s, CDMOs and clinical cusp novel therapies. The company’s head office and labs are at Melbourne’s Jumar BioIncubator. David is a growth-focused strategy, business operations and commercialisation specialist. He has over 20 years’ experience leading the development and deployment of automated biological production systems – across cell, gene and tissue therapies, ancillary materials, and medical devices. David has supported the manufacturing implementation of many of the world’s approved ATMPs, working with customers worldwide.
Jumar serves as a ‘first home’ for young biotech ventures, providing you with affordable lab and office space and the practical support to unlock the potential of your early scientific discoveries. Companies in residence become part of a vibrant community, with access to world-class facilities, a dedicated team to lean on, as well as curated entrepreneurial training and events.
By connecting young companies to all the practical support they need to overcome early challenges, we help steward the creation of a thriving biotechnology ecosystem.